SARAGOVI; Horacio Uri

Patent Applications and Registrations

Patent applications and USPTO patent grants for SARAGOVI; Horacio Uri.The latest application filed is for "neurotrophin mutants and use thereof for treating neurodegenerative diseases and disorders".

Company Profile

6.11.19

SARAGOVI; Horacio Uri - Montreal CA
Saragovi; Horacio Uri - Westmount CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Neurotrophin Mutants And Use Thereof For Treating Neurodegenerative Diseases And Disorders App 20210179684 - SARAGOVI; Horacio Uri	2021-06-17
Treatment using truncated Trk B and Trk C antagonists Grant 11,034,961 - Saragovi , et al. June 15, 2	2021-06-15
Trkb Or Trkc Agonist Compositions And Methods For The Treatment Of Otic Conditions App 20200190201 - SARAGOVI; Horacio Uri ; et al.	2020-06-18
Neurotrophin Mutants For Treating Hearing Loss And Other Otic Disorders App 20190374606 - FOSTER; Alan ; et al.	2019-12-12
Carbohydrate Structures And Uses Thereof App 20190343941 - SARAGOVI; Horacio Uri ; et al.	2019-11-14
Anti-ganglioside compound for targeting cancer and generating antibodies Grant 10,363,305 - Saragovi , et al.	2019-07-30
Treatment Using Truncated Trk B And Trk C Antagonists App 20190017053 - SARAGOVI; Horacio Uri ; et al.	2019-01-17
Treatment using truncated Trk B and Trk C antagonists Grant 10,066,229 - Saragovi , et al. September 4, 2	2018-09-04
Beta-turn peptidomimetic cyclic compounds for treating dry eye Grant 9,707,267 - Cumberlidge , et al. July 18, 2	2017-07-18
Truncated Trk B And Trk C Antagonists And Uses Thereof App 20170029823 - Saragovi; Horacio Uri ; et al.	2017-02-02
Trkb Or Trkc Agonist Compositions And Methods For The Treatment Of Otic Conditions App 20170029511 - Saragovi; Horacio Uri ; et al.	2017-02-02
Treatment Using Truncated Trk B And Trk C Antagonists App 20170029822 - Saragovi; Horacio Uri ; et al.	2017-02-02
Anti-ganglioside Compound For Targeting Cancer And Generating Antibodies App 20160303227 - SARAGOVI; Horacio Uri ; et al.	2016-10-20
Agonistic Antibodies To Trkc Receptors And Uses Thereof App 20160130363 - Saragovi; Horacio Uri ; et al.	2016-05-12
Inhibitors of p75 receptor and their uses Grant 9,296,691 - Saragovi , et al. March 29, 2	2016-03-29
Agonistic antibodies to TrkC receptors and uses thereof Grant 9,200,080 - Saragovi , et al. December 1, 2	2015-12-01
Agonistic Antibodies To Trkc Receptors And Uses Thereof App 20140004119 - Saragovi; Horacio Uri ; et al.	2014-01-02
Inhibitors Of P75 Receptor And Their Uses App 20130310404 - Saragovi; Horacio Uri ; et al.	2013-11-21
.beta.-turn peptidomimetic cyclic compounds Grant 6,881,719 - Saragovi , et al. April 19, 2	2005-04-19
Beta turn peptidomimetic cyclic compounds App 20030211982 - Saragovi, Horacio Uri ; et al.	2003-11-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.